Pendium

Step 1 of 9

skinbetter science owns the clinical retinoid conversation in AI—now it's time to win the rest of the regimen.

With a strong visibility score of 76, your lead is real. Here is the read on where you are winning and where competitors are starting to catch up.

skinbetter science's baseline score
76/100
Good

skinbetter science enjoys high visibility as a canonical medical-grade brand, particularly for its AlphaRet line. While it leads in 'best of' editorial-based AI responses, there is an opening to dominate more specific patient journey prompts regarding post-procedure care and volumizing treatments.

What we see
  • Skinbetter Science dominates the 'medical grade' and 'dermatologist recommended' conversational categories in AI answers.
  • ChatGPT and Gemini frequently mention the brand alongside SkinCeuticals in comparisons of antioxidant serums.
  • Visibility for specific conditions like rosacea is growing but lags behind heritage medical brands like Obagi.
  • The brand is highly cited in Reddit's r/30pluskincare, which provides a strong sentiment anchor for LLMs.
  • AI Overviews consistently pull Skinbetter into featured snippets for high-intent clinical skincare queries.
Business goals skinbetter science is likely trying to hit
  • Defend market share against direct-to-consumer medical-grade rivals
  • Increase patient-to-provider conversion via the 'find a professional' tool
  • Maintain premium clinical positioning after L'Oreal acquisition
  • Boost awareness of the new Ampra volumizing serum line